S100A8 and systemic lupus erythematosus: Compared with routine inflammation indexes, including CRP, S100A8/A9 is becoming a more sensitive biomarker for inflammation activity and response to therapy (132), especially for RA, juvenile idiopathic arthritis, SLE, and a few other inflammatory diseases (8, 133, 134).